The effect of Platycodin D on the expression of cytoadherence proteins P1 and P30 in Mycoplasma pneumoniae models

Area of Science:

• Pharmacology
• Microbiology
• Traditional Chinese Medicine

Background:

• Platycodin D is a primary active compound in Qinbaiqingfei pellet (Qinbai), a clinically approved Traditional Chinese Medicine in China.
• Qinbai is recognized for its efficacy against Mycoplasma pneumoniae infections.
• Previous research established Platycodin D's anti-M. pneumoniae activity with a Minimum Inhibitory Concentration (MIC) of 16 μg/ml.

Purpose of the Study:

• To elucidate the mechanism of action of Platycodin D against Mycoplasma pneumoniae.
• To investigate the effect of Platycodin D on the expression of M. pneumoniae adhesion proteins P1 and P30.

Main Methods:

• Reverse transcription PCR (RT-PCR) was employed to quantify P1 and P30 gene expression.
• Experiments were conducted on M. pneumoniae strains, infected BALB/c mice, and infected A549 cell lines.

Main Results:

• Platycodin D significantly inhibited the expression of M. pneumoniae adhesion proteins P1 and P30.
• A dose-dependent effect was observed, with higher concentrations of Platycodin D showing a greater inhibitory impact.
• The inhibition of P1 and P30 expression was consistent across in vitro and in vivo models.

Conclusions:

• Platycodin D exerts its anti-M. pneumoniae effects, at least in part, by suppressing the expression of adhesion proteins P1 and P30.
• This mechanism provides a scientific basis for the traditional use of Qinbai in treating M. pneumoniae infections.
• Further research into the detailed mechanisms of Qinbai is warranted.